勘误：靶向蛋白质组学确定的多生物标志物谱为晚期宫颈癌的预后和免疫治疗反应开发了分类器。
Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.
作者信息
Li Jin, Zhang Xu, Yang Liuke, Zhu Youwei, Gao Rongrong, Zhang Tiancheng, Chen Xuwen, Fu Jun, He Gaoyang, Shi Huijuan, Peng Shenjie, Wu XiaoHua
机构信息
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
出版信息
Front Immunol. 2024 Jul 2;15:1437676. doi: 10.3389/fimmu.2024.1437676. eCollection 2024.
Abstract
[This corrects the article DOI: 10.3389/fimmu.2024.1391524.].
摘要
[本文更正了文章DOI：10.3389/fimmu.2024.1391524。]
相似文献
1
Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.勘误：靶向蛋白质组学确定的多生物标志物谱为晚期宫颈癌的预后和免疫治疗反应开发了分类器。
Front Immunol. 2024 Jul 2;15:1437676. doi: 10.3389/fimmu.2024.1437676. eCollection 2024.
2
Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.靶向蛋白质组学确定的多生物标志物特征开发的分类器用于预测晚期宫颈癌的预后和免疫治疗反应。
Front Immunol. 2024 May 21;15:1391524. doi: 10.3389/fimmu.2024.1391524. eCollection 2024.
3
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.勘误：一种用于预测甲状腺癌预后和免疫治疗的新型衰老相关生物标志物的鉴定与验证
Front Immunol. 2023 Jun 5;14:1229541. doi: 10.3389/fimmu.2023.1229541. eCollection 2023.
4
Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.勘误：靶向CD44递送包裹于硫醇化壳聚糖中的溶瘤新城疫病毒用于宫颈癌的持续释放：一种靶向免疫治疗方法。
Front Immunol. 2024 Mar 11;15:1391710. doi: 10.3389/fimmu.2024.1391710. eCollection 2024.
5
Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.勘误：肿瘤内三级淋巴结构评估可预测结直肠癌患者的预后及免疫治疗反应。
Front Immunol. 2024 Jun 14;15:1397764. doi: 10.3389/fimmu.2024.1397764. eCollection 2024.
6
Corrigendum: Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study.勘误：补体调理的HIV调节参与宫颈黏膜组织感染的途径：一项转录组学和蛋白质组学研究。
Front Immunol. 2021 Jul 8;12:730130. doi: 10.3389/fimmu.2021.730130. eCollection 2021.
7
Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.勘误：抗原呈递机制特征衍生的CALR介导胶质瘤中巨噬细胞的迁移、极化并预测免疫治疗反应。
Front Immunol. 2022 Jun 2;13:931433. doi: 10.3389/fimmu.2022.931433. eCollection 2022.
8
Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.勘误：泛癌分析表明，ALKBH5是包括胶质瘤在内的多种癌症类型的潜在预后和免疫治疗生物标志物。
Front Immunol. 2022 Jun 23;13:944740. doi: 10.3389/fimmu.2022.944740. eCollection 2022.
9
Corrigendum: Modulation of immune response by nanoparticle-based immunotherapy against food allergens.勘误：基于纳米颗粒的食物过敏原免疫疗法对免疫反应的调节
Front Immunol. 2023 Dec 6;14:1332906. doi: 10.3389/fimmu.2023.1332906. eCollection 2023.
10
Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction.勘误：非靶向代谢组学确定犬尿氨酸为急性心肌梗死的预测性预后生物标志物。
Front Immunol. 2023 Mar 8;14:1163419. doi: 10.3389/fimmu.2023.1163419. eCollection 2023.
Zotero 插件